Sysmex Inostics, a subsidiary of Sysmex Corp., announced that its OncoBEAM RAS CRC test was granted CE mark approval. The CE mark is a mandatory conformity marking for certain products sold within the European Economic Area. The test, developed by Sysmex Inostics GmbH in collaboration with Merck, can now be accessed by patients with metastatic...
When The Cancer Letter founder Jerry Boyd carried the first print run of his little eight page oncology newsletter into an NCAB meeting in 1973, he certainly could not have predicted that, half a century later, his experiment would branch out into this thing called “podcasts.”
